ArticleCardiovascular and interventional radiology2023
Outcomes of Self-Expanding Covered Stents for the Treatment of External ILIAC Artery Obstructive Disease.
Article in Cardiovascular and interventional radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 15 citations in OpenAlex.
- Stent Diameter, Not Sex, Is Predictive of Reintervention after Common Iliac Artery Stenting.Annals of vascular surgery · 2026Article
- Long-term patency of aortoiliac stenting with or without simultaneous infrainguinal revascularization: a propensity score-matched 10-year retrospective cohort study.Annals of surgical treatment and research · 2026Article
- Endovascular Repair of Large Iliac Artery Pseudoaneurysm after Remote Transplant Nephrectomy.The International journal of angiology : official publication of the International College of Angiology, Inc · 2026Article
- Dynetic-35 cobalt chromium balloon-expandable stent for iliac lesions: 12-month results of the BIONETIC-I multi-center study.CVIR endovascular · 2025Article
- Short-term outcomes of the iCover balloon-expandable covered stent for iliac artery lesions.Diagnostic and interventional radiology (Ankara, Turkey) · 2025Article
- Early outcomes of drug-coated balloon angioplasty and stent placement for the treatment of iliac artery lesions.Frontiers in surgery · 2025Article
- Viabahn endoprosthesis for femoropopliteal aneurysm repair: safety, success rates, and long-term patency.CVIR endovascular · 2024Article
- Do We Really Need Expensive Stent-Grafts to Treat External Iliac Artery Lesions Effectively?Cardiovascular and interventional radiology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo describe the early results and mid-term patency rates of external iliac artery (EIA) stenting using self-expanding covered stents.
methodsWe conducted a multicenter retrospective study (2015-2021), including patients receiving primary endovascular treatment of external iliac artery occlusive disease with self-expanding covered stents. All patients were treated with the Viabahn (W.L Gore & Associates, Inc., Flagstaff, AZ-USA) stent. Patency and limb salvage rates were estimated with Kaplan-Meier curves.
resultsNinety-three patients (mean age, 69 ± 9 years; 81% males) were treated for disabling claudication in 44%, rest pain in 28%, and tissue loss in 28%. TASC C/D lesions were present in 72% and iliac complete occlusion in 30%. Mean lesion length was 6.9 ± 2.4 cm; 30% had moderate/severe EIA calcifications; and the mean iliac tortuosity index was 1.17 ± 0.13. Technical success was 100%. There was one perioperative death (1.4%) and procedural complication rate was 6.5%. At 42 months (mean, 25 months), primary patency was 89.8% (95%CI 83-98); the presence of EIA tortuosity (tortuosity index > 1.25, 87.7 ± 11% vs 89.9 ± 8%; P = .6) or severe calcifications (87.6 ± 9% vs 96.0 ± 8%; P = .400) had no significant impact. After univariate analysis, the use of a stent with diameter < 8 mm (HR 8.5, 95%CI 3.24-14.22; P < .001) was negatively associated with primary patency.
conclusionsThe use of self-expanding covered stents provided excellent early and mid-term results in the treatment of obstructive disease of the EIA, also in cases of high EIA tortuosity and high grade of calcifications. The use of a < 8 mm-diameter stent was associated with a reduced primary patency.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.